The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / August / Molecular Diagnostics Go Mobile
Point of care testing Technology and innovation Screening and monitoring Molecular Pathology Infectious Disease

Molecular Diagnostics Go Mobile

A smartphone-linked fluorimeter detects infectious disease and cancer biomarkers in 10-minute assays

08/31/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Report: A Dual-Port, Smartphone-Linked, Pocket-Size Fluorimeter

Overview

The VPodDuo fluorimeter identifies various nucleic acid targets and achieves detection limits similar to established laboratory methods.

Background

The development of portable diagnostic tools is crucial for enhancing access to molecular testing, particularly in resource-limited settings.

Data Highlights

TargetVPODDuo Detection LimitLaboratory Instrument Detection Limit
Zika virus10,000 copies/µL10,000 copies/µL
Methicillin-susceptible S. aureus100 copies/µL10 copies/µL
HIV target (CRISPR)7 pM8 pM
L858R EGFR mutation29 pM47 pM
miR-375-3p500 pM500 pM

Key Findings

  • VPODDuo measures fluorescent signals for molecular assays effectively.
  • It allows simultaneous assessment of test samples and negative controls.
  • Detection limits for Zika virus and HIV targets are comparable to laboratory instruments.
  • The device operates effectively in outdoor settings and varying temperatures.
  • Further studies are needed to evaluate clinical diagnostic accuracy and sample preparation.

Clinical Implications

The VPodDuo may enhance access to essential diagnostic services in various healthcare settings.

Conclusion

The VPodDuo fluorimeter warrants further investigation into its clinical applications and performance with patient specimens.

Related Resources & Content

  1. A Dual-Port, Smartphone-Linked, Pocket-Size Fluorimeter for Rapid Molecular Diagnostic Assays at Point of Care, IEEE Sensors Journal, 2026 -- Study Overview
  2. the pathologist — A Smart Approach to Testing, 2017 -- Mobile Diagnostics
  3. the pathologist — Mobile Phone Microscopy, 2017 -- Affordable Diagnostics
  4. the pathologist — Smartphone DNA Sequencing Analysis with iGenomics, 2021 -- DNA Analysis
  5. WHO recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis, 2026 -- WHO Guidelines
  6. Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review - PMC, 2026 -- Systematic Review
  7. the analytical scientist — DNA Imaging On-the-Go
  8. WHO recommends near point-of-care tests, tongue swabs, and sputum pooling for TB diagnosis
  9. Point-of-Care Nucleic Acid Amplification Tests for Respiratory Syncytial Virus Detection in Children and Adults: A Systematic Literature Review - PMC
  10. A Dual-Port, Smartphone-Linked, Pocket-Size Fluorimeter for Rapid Molecular Diagnostic Assays at Point of Care - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.